Cytogenetic responses in chronic myeloid leukemia patients treated with imatinib mesylate

被引：0
|
作者：
Babameto-Laku, A. [1 ]
Mokin, V. [1 ]
Cikuli, M. [1 ]
Xhumari, P. [2 ,3 ]
机构：
[1] Univ Hosp Ctr, Serv Med Genet, Tirana, Albania
[2] Univ Hosp Ctr, Haematol Serv, Tirana, Albania
[3] Fac Med, Tirana, Albania
来源：
CHROMOSOME RESEARCH | 2005年 / 13卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [1] Changes of Immunological, Cytogenetic and Haematological Profiles in Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Gaiz, Almottesembellah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S286 - S286
  • [2] Hematologic and cytogenetic response to imatinib mesylate in chronic myeloid leukemia
    Narayanan, G.
    Chacko, D. J.
    Koshy, A. A.
    Soman, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S18 - S18
  • [3] Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate
    Espinet, Blanca
    Carla Oliveira, Ana
    Boque, Concepcion
    Domingo, Alicia
    Alonso, Esther
    Sole, Francesc
    HAEMATOLOGICA, 2005, 90 (04) : 556 - 558
  • [4] Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
    Arora, B
    Kumar, L
    Sharma, A
    Wadhwa, J
    Kochupillai, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 358 - 359
  • [5] Nutritional Status of Patients with Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Jose Castillo-Martinez, Maria
    Juventina Tuna-Aguilar, Elena
    del Pilar Milke-Garcia, Maria
    Camacho Zamora, Anais
    Villegas Cervantes, Viviana
    Castillo-Martinez, Lilia
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (09): : 3211 - 3216
  • [6] Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ chronic myeloid leukemia patients treated with imatinib mesylate
    Fugazza, G
    Miglino, M
    Bruzzone, R
    Quintino, S
    Gatti, AM
    Grasso, R
    Gobbi, M
    Frassoni, F
    Sessarego, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (02): : 295 - 299
  • [7] Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate
    Atagunduz, Isik Kaygusuz
    Toptas, Tayfur
    Deniz, Rabia
    Kara, Osman
    Eser, All
    Sezgin, Aslihan
    Ozgumus, Toluy
    Gecgel, Fatma
    Tuglularl, Tulin Firatli
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (02): : 120 - 125
  • [8] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
    Hasford, J
    Pfirrmann, M
    Hochhaus, A
    LEUKEMIA, 2005, 19 (04) : 497 - 499
  • [9] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
    J Hasford
    M Pfirrmann
    A Hochhaus
    Leukemia, 2005, 19 : 497 - 499
  • [10] Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate
    Jabbour, E
    Kantarjian, H
    O'Brien, S
    Rios, MB
    Abruzzo, L
    Verstovsek, S
    Garcia-Manero, G
    Cortes, J
    BLOOD, 2006, 107 (02) : 480 - 482
12345